PET imaging agent may allow early measurement of efficacy of breast cancer therapy

PET Imaging Agent May Allow Early Measurement Of Efficacy Of Breast Cancer Therapy paper is one attributed to those Health and Medical Updates categories, posted much as our publisher Linda Norton during February 11, 2019, these essay maybe want to search by that hastag agent, Breast, cancer, early, efficacy, imaging, measurement, PET, therapy. I'm joyful to joyful you as well providing those other blogpost attributed health together with we always posting that post everyday.

Petimagingag.jpg

Representative coronal 18F-FFNP PET/CT images of MDA-MB-231 (red arrow), 231 PR-A (white arrows), and 231 PR-B (yellow arrow) tumor xenografts (19 d after implantation) from 12 mice imaged 1 h after injection with 10 MBq (270 μCi) of 18F-FFNP. Physiologic uptake from hepatobiliary clearance is also visualized. Credit: K Salem et al., University of Wisconsin School of Medicine and Public Health, Madison, WI

Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients, according to new research published in the February issue of The Journal of Nuclear Medicine. Researchers report that positron emission tomography (PET) imaging with 18F-fluorofuranylnorprogesterone (18F-FFNP) has been found to successfully measure changes in progesterone receptor (PR) levels resulting from a short-course estrogen treatment, also known as an estradiol challenge.

Estrogen-receptor (ER)-positive breast cancer is the most common class of breast cancer, affecting nearly 70 percent of patients. By participating in an estradiol challenge, physicians can determine the likelihood of potential benefit of hormonal therapies targeting ER for individual patients. Many hormone therapies interfere with the ability of estrogen to regulate the expression of PR protein, which is more pronounced in the presence of estrogen. As such, several PET tracers have been developed to monitor and analyze changes in the PR level during therapy. “Typically, anatomic size and proliferation biomarkers are analyzed to determine endocrine sensitivity,” said Amy M. Fowler, MD, Ph.D., assistant professor, Section of Breast Imaging, Department of Radiology, University of Wisconsin-Madison. “However, non-invasive detection of changes in PR expression with 18F-FFNP during an estradiol challenge may be an earlier indicator of the effectiveness of a specific hormone therapy.”

In this study, T47D human breast cancer cells (cells with estrogen and progesterone receptors, but without human epidermal growth factor receptor-2) and mice bearing T47D tumor xenografts were treated with estrogen to increase PR expression. The cells and mice were imaged with 18F-FFNP, and assays were conducted for cell uptake and tissue biodistribution. To investigate the separate role of PR-A and PR-B isoforms on overall 18F-FFNP binding, triple-negative MDA-MB-231 breast cancer cells were engineered to express either PR-A or PR-B. In vitro 18F-FFNP binding was measured by saturation and competitive binding assays, while in vivo uptake was measured with PET imaging.

In T47D cells treated with estrogen, an increase in 18F-FFNP uptake was measured at 48 hours after treatment; in mice with T47D tumor xenografts, increased uptake was seen at 48 and 72 hours after treatment. This increase in 18F-FFNP uptake also correlated with an increase in PR protein expression and proliferation. Results showed that there was no significant preferential 18F-FFNP binding or uptake by PR-A versus PR-B in PR isoform cell lines or tumor xenografts. “This is an important finding given the variability of PR isoform expression observed in breast cancer patients,” stated Fowler.

She continued, “Validation of PR imaging as a biomarker of endocrine sensitivity in patients before and after estradiol challenge could provide new opportunities in the field of molecular imaging and nuclear medicine for breast cancer imaging. Improved methods for testing endocrine sensitivity in patients could better inform decisions for optimal individualized ER-positive breast cancer therapy, potentially reducing morbidity and mortality.”


Imaging agents predict breast cancer response to endocrine therapy


More information:
Kelley Salem et al, Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer, Journal of Nuclear Medicine (2018). DOI: 10.2967/jnumed.118.211516


Provided by
Society of Nuclear Medicine and Molecular Imaging


You maybe want to go through anothers post health just as our linked section or you can check it at noted chapter, I always updating these health chapter daily for information along with cue as well as methode to supporting our health as well living this healthy lifestyle. Those part is updated upon Linda Norton with this title PET Imaging Agent May Allow Early Measurement Of Efficacy Of Breast Cancer Therapy.

Related posts of "PET imaging agent may allow early measurement of efficacy of breast cancer therapy"

Breast cancer screening age should be lowered to 35

New clinical trial findings suggest that thousands of women who have a family history of breast cancer should be screened from the age of 35, rather than the current eligibility age of 40. Tyler Olson | Shutterstock The findings, which were gathered from 34 screening centers, suggest that changing the age of screening to 35...

A fear of regret can lock us into bad relationships, jobs and habits – here’s how to break free

How many times have you thought about starting a company, taking a year out to write that novel or leaving a loveless relationship but ended up doing nothing about it? A fear of regret – which is a powerful driver of maintaining the status quo in our lives – may be to blame. As research...

Most students receiving spectacles wear them at follow-up

(HealthDay)—Three-quarters of students aged 11 to 15 years from government schools in India receiving spectacles wear them at follow-up, according to a study published online Jan. 31 in JAMA Ophthalmology. Priya Morjaria, Ph.D., from the London School of Hygiene and Tropical Medicine, and colleagues examined predictors of spectacle wear in 460 students aged 11 to...

Layer up during the polar vortex

(HealthDay)— As a giant polar vortex sweeps down over most of the United States, bringing with it temperatures so frigid that frostbite and hypothermia can happen within minutes, doctors have some advice for those who dare to venture outside. The swath of the cold freeze is so wide and deep that roughly 75 percent of...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.